Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-02-010852
Filing Date
2002-11-14
Accepted
2002-11-14 11:33:49
Documents
7
Period of Report
2002-03-31

Document Format Files

Seq Description Document Type Size
1 ALKERMES, INC. b44764a1e10vkza.htm 10-K/A 923080
3 EX-23 CONSENT OF DELOITTE AND TOUCHE LLP b44764a1exv23.htm EX-23 977
4 EX-99.1 906 CERTIFICATION BY CHIEF EXEC OFFICER b44764a1exv99w1.txt EX-99.1 1296
5 EX-99.2 906 CERTIFICATION BY CHIEF FIN. OFFICER b44764a1exv99w2.txt EX-99.2 1308
6 COURTESY PDF COPY OF ALKERMES 10-K/A b44764a1e10vkzaxpdfy.pdf 10-K/A 995677
7 GRAPHIC b44764a1xbox.gif GRAPHIC 1270
8 GRAPHIC b44764a1box.gif GRAPHIC 1221
  Complete submission text file 0000950123-02-010852.txt   1927024
Mailing Address
Business Address 88 SIDNEY ST CAMBRIDGE MA 02139-4136 617-494-0171
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 001-14131 | Film No.: 02822766
SIC: 2834 Pharmaceutical Preparations